1. Home
  2. TSHA vs TH Comparison

TSHA vs TH Comparison

Compare TSHA & TH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • TH
  • Stock Information
  • Founded
  • TSHA 2019
  • TH 1978
  • Country
  • TSHA United States
  • TH United States
  • Employees
  • TSHA N/A
  • TH N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • TH Hotels/Resorts
  • Sector
  • TSHA Health Care
  • TH Consumer Discretionary
  • Exchange
  • TSHA Nasdaq
  • TH Nasdaq
  • Market Cap
  • TSHA 728.4M
  • TH 692.6M
  • IPO Year
  • TSHA 2020
  • TH N/A
  • Fundamental
  • Price
  • TSHA $3.36
  • TH $8.78
  • Analyst Decision
  • TSHA Strong Buy
  • TH Buy
  • Analyst Count
  • TSHA 7
  • TH 3
  • Target Price
  • TSHA $8.71
  • TH $13.00
  • AVG Volume (30 Days)
  • TSHA 3.5M
  • TH 465.8K
  • Earning Date
  • TSHA 08-12-2025
  • TH 08-07-2025
  • Dividend Yield
  • TSHA N/A
  • TH N/A
  • EPS Growth
  • TSHA N/A
  • TH N/A
  • EPS
  • TSHA N/A
  • TH 0.10
  • Revenue
  • TSHA $8,098,000.00
  • TH $310,382,000.00
  • Revenue This Year
  • TSHA N/A
  • TH N/A
  • Revenue Next Year
  • TSHA N/A
  • TH N/A
  • P/E Ratio
  • TSHA N/A
  • TH $84.18
  • Revenue Growth
  • TSHA N/A
  • TH N/A
  • 52 Week Low
  • TSHA $1.05
  • TH $4.00
  • 52 Week High
  • TSHA $3.40
  • TH $11.10
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 70.13
  • TH 58.96
  • Support Level
  • TSHA $2.79
  • TH $8.62
  • Resistance Level
  • TSHA $2.99
  • TH $9.16
  • Average True Range (ATR)
  • TSHA 0.16
  • TH 0.29
  • MACD
  • TSHA 0.03
  • TH -0.03
  • Stochastic Oscillator
  • TSHA 93.71
  • TH 63.64

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. Its operating segment includes HFS-South and HFS-Midwest; Government; TCPL Keystone and others. It generates a majority of its revenue from the Government segment which consists of specialty rental and vertically integrated hospitality services revenue from customers with Government contracts located in Texas.

Share on Social Networks: